The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

Krabansky F, Azzouz B, Biya J, Abou Taam M, Morel A, Trenque T

Eosinophilic pneumonia induced by non-steroidal anti-inflammatory drugs: An underestimated risk.

Therapie. 2018;73(6):473-482

Kohlhäufl M, Weber N, Morresi-Hauf A, Geiger D, Raith H, Häussinger K

[Pulmonary infiltrates with blood eosinophilia in a 62-year-old patient].

Der Internist. 2003;44(8):1037-41

Khalil H, Molinary E, Stoller JK

Diclofenac (Voltaren)-induced eosinophilic pneumonitis. Case report and review of the literature.

Archives of internal medicine. 1993;153(14):1649-52